Noked Israel’s VanEck Pharmaceutical ETF PPH Stock Holding History

Noked Israel’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-140,000	Closed	-$9.41M	–	43
2022 Q3	$9.41M	Hold	140,000	–	–	2.29%	15
2022 Q2	$10.8M	Buy	+140,000	New	+$10.9M	2.47%	11

Other funds holding PPH

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

VAS

Valicenti Advisory Services Elmira, New York $530M AUM 46.5% 1-Year Est. Return

Noked Israel's PPH Position: Q4 2022 in Review

Noked Israel sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2022, closing a stake of 140,000 shares — an estimated $9.41M sold.

Noked Israel first reported a position in PPH in Q2 2022 and held it in 2 quarters. The position peaked at $10.8M in Q2 2022. 114 funds tracked by Wall St. Rank hold PPH as of Q4 2022.

Noked Israel reported no remaining VanEck Pharmaceutical ETF position as of Q4 2022 after selling out during the quarter.
Noked Israel sold 140,000 VanEck Pharmaceutical ETF shares in Q4 2022, an estimated $9.41M.
Noked Israel first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and held it in 2 quarters.
Noked Israel's VanEck Pharmaceutical ETF position peaked at $10.8M in Q2 2022.
114 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2022.

Based on Noked Israel's 13F filing for Q4 2022, filed 14 Feb 2023.